I now have comprehensive information from multiple authoritative sources. Let me compile a thorough answer.
Mechanism of Urticaria
Urticaria (hives) is fundamentally a disorder of cutaneous mast cell degranulation leading to transient dermal microvascular hyperpermeability, plasma extravasation, and sensory nerve activation — producing the classic wheal-and-flare response with pruritus. — Fitzpatrick's Dermatology, Robbins & Cotran Pathologic Basis of Disease
The Central Pathway: Mast Cell Degranulation
Dermal mast cells are the central effectors. When activated, they release:
Preformed (granule) mediators — released within minutes:
- Histamine — binds H1 receptors on postcapillary venule endothelium → vasodilation and increased vascular permeability → wheal; binds sensory nerves → pruritus
- Tryptase, chymase — serine proteases that amplify inflammation
Newly synthesized mediators — generated via arachidonic acid:
- Prostaglandins (PGD₂) — vasodilation, itch
- Leukotrienes (LTC₄, LTD₄) — potent vasodilators and bronchoconstrictors
- Platelet-activating factor (PAF) — increases vascular permeability
Cytokines (TNF-α, IL-4, IL-5, IL-13) — sustain the inflammatory response
The net result: vasodilation + plasma extravasation into the dermis = wheal (edema); surrounding erythema from arteriolar vasodilation (flare); pruritus from direct sensory nerve stimulation by histamine and kinins. — Rosen's Emergency Medicine
Classification by Mechanism
1. Mast Cell-Dependent, IgE-Dependent (Type I Hypersensitivity)
This is the classic allergic mechanism:
- Sensitization phase: On first antigen exposure (pollen, food, drugs, insect venom), Th2 cells produce IL-4 and IL-13, driving B-cell class switching → antigen-specific IgE is produced and binds to high-affinity FcεRI receptors on dermal mast cells and circulating basophils
- Elicitation phase: Re-exposure to the same antigen cross-links adjacent FcεRI-bound IgE molecules, triggering a signaling cascade:
- Activation of SYK → LAT → PLCγ → PKC
- Rise in intracellular Ca²⁺
- Explosive mast cell degranulation with release of histamine and other mediators
Symptoms typically develop within 15 minutes to 1 hour of antigen exposure. Despite being the best-understood mechanism, classical type I allergy accounts for less than 10% of all urticaria cases. — Fitzpatrick's Dermatology
Figure: The pathogenesis of autoimmune urticaria and mechanism of action of omalizumab — Fitzpatrick's Dermatology
2. Autoimmune Mechanism (IgE-Dependent variant — Chronic Spontaneous Urticaria)
One-third to one-half of chronic spontaneous urticaria (CSU) cases have a detectable autoimmune basis:
- Anti-FcεRI IgG autoantibodies: Directly bind and cross-link the high-affinity IgE receptor on mast cells/basophils → degranulation (complement-dependent, via C5a)
- Anti-IgE IgG autoantibodies: Cross-link IgE itself while it is bound to FcεRI → same downstream result
- These can be detected by the autologous serum skin test (ASST) and the basophil histamine release test
- The complement fragment C5a amplifies degranulation
This explains why omalizumab (anti-IgE monoclonal antibody) works in CSU: by sequestering free IgE, it depletes IgE available to bind FcεRI, gradually downregulating FcεRI expression on mast cells, reducing their reactivity. — Fitzpatrick's Dermatology
3. Mast Cell-Dependent, IgE-Independent
Certain substances directly trigger mast cell degranulation without prior IgE sensitization:
- Opiates (morphine, codeine), vancomycin, radiocontrast media — direct mast cell degranulation via MRGPRX2 receptor
- Foods (lobster, strawberries) — direct histamine release, non-immunologic
- No prior sensitization required; can occur on first exposure
4. Mast Cell-Independent, IgE-Independent
These mechanisms bypass mast cells altogether:
- Aspirin/NSAIDs: Inhibit cyclooxygenase (COX-1) → shunt arachidonic acid toward the lipoxygenase pathway → excess leukotrienes → vascular permeability. The precise mechanism is not fully elucidated, and effects can persist weeks after ingestion
- Hereditary angioedema (HAE): Deficiency of C1 inhibitor → unregulated activation of the early complement cascade and contact activation system → generation of bradykinin → binds B2 receptors on postcapillary venule endothelium → vasodilation and edema (notably mast cell-independent; antihistamines are ineffective in pure HAE)
- ACE inhibitors: Block bradykinin degradation → bradykinin accumulation → angioedema (same pathway as HAE)
— Robbins & Cotran Pathologic Basis of Disease
5. Neurogenic Mechanism
Cutaneous mast cells express receptors for numerous neuropeptides — substance P, vasoactive intestinal peptide (VIP), somatostatin, neurokinin A/B, CGRP, ACTH, and acetylcholine. In cholinergic urticaria, excessive acetylcholine release from cholinergic nerve terminals (in response to heat/exercise/sweating) directly activates mast cells. Two thirds of cholinergic urticaria patients are also sensitized to antigens in human sweat (specifically MGL_1304, a protein from Malassezia globosa), explaining the IgE-mediated overlap. — Fitzpatrick's Dermatology
Summary Table
| Mechanism | Key Mediator | Example Triggers | IgE? | Mast Cell? |
|---|
| Type I hypersensitivity | Histamine, leukotrienes | Foods, drugs, insect venom | ✅ Yes | ✅ Yes |
| Autoimmune (anti-FcεRI/anti-IgE IgG) | Histamine, C5a | Idiopathic CSU | ✅ Yes | ✅ Yes |
| Direct mast cell degranulation | Histamine | Opiates, contrast media | ❌ No | ✅ Yes |
| COX inhibition (aspirin) | Leukotrienes | NSAIDs | ❌ No | ✅ Yes |
| Bradykinin (HAE/ACEi) | Bradykinin | C1-inh deficiency, ACEi | ❌ No | ❌ No |
| Neurogenic | Histamine, acetylcholine | Heat, exercise, sweat | ± | ✅ Yes |
Histopathology
Regardless of mechanism, the histological features of urticaria are subtle:
- Widened collagen bundles (dermal edema)
- Dilated dermal lymphatics
- Sparse superficial perivenular infiltrate: mononuclear cells, rare neutrophils, ± eosinophils
- No epidermal changes (this distinguishes urticaria from eczema)
— Robbins & Cotran Pathologic Basis of Disease